201 related articles for article (PubMed ID: 35350991)
21. Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants.
Dangor Z; Kwatra G; Izu A; Lala SG; Madhi SA
Expert Rev Vaccines; 2015 Jan; 14(1):135-49. PubMed ID: 25242617
[TBL] [Abstract][Full Text] [Related]
22. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
Kobayashi M; Schrag SJ; Alderson MR; Madhi SA; Baker CJ; Sobanjo-Ter Meulen A; Kaslow DC; Smith PG; Moorthy VS; Vekemans J
Vaccine; 2019 Nov; 37(50):7307-7314. PubMed ID: 28017431
[TBL] [Abstract][Full Text] [Related]
23. Relationship between intrapartum antibiotic prophylaxis and group B streptococcal colonization dynamics in Japanese mother-neonate pairs.
Shibata M; Morozumi M; Maeda N; Komiyama O; Shiro H; Iwata S; Ubukata K
J Infect Chemother; 2021 Jul; 27(7):977-983. PubMed ID: 33610482
[TBL] [Abstract][Full Text] [Related]
24. The Italian arm of the PREPARE study: an international project to evaluate and license a maternal vaccine against group B streptococcus.
Berardi A; Cassetti T; Creti R; Vocale C; Ambretti S; Sarti M; Facchinetti F; Cose S; ; Heath P; Le Doare K
Ital J Pediatr; 2020 Oct; 46(1):160. PubMed ID: 33115542
[TBL] [Abstract][Full Text] [Related]
25. Group B Streptococcus Colonization in Late Pregnancy and Invasive Infection in Neonates in China: A Population-Based 3-Year Study.
Zhu Y; Huang J; Lin XZ; Chen C
Neonatology; 2019; 115(4):301-309. PubMed ID: 30808831
[TBL] [Abstract][Full Text] [Related]
26. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
[TBL] [Abstract][Full Text] [Related]
27. Effects of Intrapartum Antibiotic Prophylaxis on Neonatal Acquisition of Group B Streptococci.
Toyofuku M; Morozumi M; Hida M; Satoh Y; Sakata H; Shiro H; Ubukata K; Murata M; Iwata S
J Pediatr; 2017 Nov; 190():169-173.e1. PubMed ID: 29144242
[TBL] [Abstract][Full Text] [Related]
28. Rapid intrapartum test for maternal group B streptococcal colonisation and its effect on antibiotic use in labouring women with risk factors for early-onset neonatal infection (GBS2): cluster randomised trial with nested test accuracy study.
Daniels JP; Dixon E; Gill A; Bishop J; Wilks M; Millar M; Gray J; Roberts TE; Plumb J; Deeks JJ; Hemming K; Khan KS; Thangaratinam S;
BMC Med; 2022 Jan; 20(1):9. PubMed ID: 35027057
[TBL] [Abstract][Full Text] [Related]
29. Prospects for preventing infant invasive GBS disease through maternal vaccination.
Madhi SA; Dangor Z
Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.
Benitz WE; Gould JB; Druzin ML
Pediatrics; 1999 Jun; 103(6):e77. PubMed ID: 10353974
[TBL] [Abstract][Full Text] [Related]
31. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women.
Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
Clin Microbiol Infect; 2015 Jun; 21(6):568.e13-21. PubMed ID: 25680313
[TBL] [Abstract][Full Text] [Related]
32. Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
Madhi SA; Anderson AS; Absalon J; Radley D; Simon R; Jongihlati B; Strehlau R; van Niekerk AM; Izu A; Naidoo N; Kwatra G; Ramsamy Y; Said M; Jones S; Jose L; Fairlie L; Barnabas SL; Newton R; Munson S; Jefferies Z; Pavliakova D; Silmon de Monerri NC; Gomme E; Perez JL; Scott DA; Gruber WC; Jansen KU
N Engl J Med; 2023 Jul; 389(3):215-227. PubMed ID: 37467497
[TBL] [Abstract][Full Text] [Related]
33. A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT.
Daniels J; Dixon EF; Gill A; Bishop J; D'Amico M; Ahmed K; Dodds J; Tryposkiadis K; Wilks M; Millar M; Husain S; Gray J; Whiley A; Moore PV; Munetsi RL; Hemming K; Roberts T; Plumb J; Deeks J; Khan KS; Thangaratinam S
Health Technol Assess; 2022 Feb; 26(12):1-82. PubMed ID: 35195519
[TBL] [Abstract][Full Text] [Related]
34. Group B Streptococcus: Trials and Tribulations.
Davies HG; Carreras-Abad C; Le Doare K; Heath PT
Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S72-S76. PubMed ID: 31205250
[TBL] [Abstract][Full Text] [Related]
35. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy.
Velaphi S; Siegel JD; Wendel GD; Cushion N; Eid WM; Sánchez PJ
Pediatrics; 2003 Mar; 111(3):541-7. PubMed ID: 12612234
[TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial.
Swamy GK; Metz TD; Edwards KM; Soper DE; Beigi RH; Campbell JD; Grassano L; Buffi G; Dreisbach A; Margarit I; Karsten A; Henry O; Lattanzi M; Bebia Z
Vaccine; 2020 Oct; 38(44):6930-6940. PubMed ID: 32883555
[TBL] [Abstract][Full Text] [Related]
37. Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines.
Dzanibe S; Madhi SA
Expert Rev Vaccines; 2018 Jul; 17(7):635-651. PubMed ID: 29961350
[TBL] [Abstract][Full Text] [Related]
38. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a prematurity-based protocol for management of infants born to mothers with Group B Streptococcus colonisation.
Zuppa AA; Alighieri G; Fracchiolla A; Galluccio C; Riccardi R; Cavani M; Romagnoli C
J Obstet Gynaecol; 2014 Nov; 34(8):673-8. PubMed ID: 24921191
[TBL] [Abstract][Full Text] [Related]
40. Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants.
Dangor Z; Kwatra G; Pawlowski A; Fisher PB; Izu A; Lala SG; Johansson-Lindbom B; Madhi SA
Vaccine; 2023 Mar; 41(10):1679-1683. PubMed ID: 36754766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
